About Author : Saipriya Iyer

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website content writing, tech writing, promotional writing, business writing, and more. Currently, she pens down articles related to the latest business trends, market research, and industry news.



Contribution by Saipriya Iyer

PharmaCyte to submit IND application to FDA for clinical trial in LAPC

PharmaCyte Biotech, a clinical-stage biotechnology company, is reportedly set to submit an IND (Investigational New Drug) application to the U.S. FDA. The IND application is related to the Phase 2b clinical trial among patients with LAPC (locally adv...

Read More
Immunic announces topline data from Phase 2 EMPhASIS, IMU-838 trial

Immunic, Inc. has recently announced positive topline results from the Phase 2 EMPhASIS trial of IMU-838, in patients with RRMS (relapsing-remitting multiple sclerosis). IMU-838 is a next-generation, orally available selective immune modulator. It in...

Read More
Ciox announces acquisition of biomed-NLP technology company, Medal

Ciox Health has recently announced the acquisition of Medal, Inc., a biomed-NLP (biomedical Natural Language Processing) technology company based in San Francisco. Medal is also a leader in integrating AI techniques for the unstructured medical recor...

Read More
Moderna & Pfizer commence late-stage COVID-19 vaccine trials in U.S.

Moderna, a biotechnology company, and NIH (National Institute of Health) have reportedly collaborated to start the Phase 3 clinical trial of a potential COVID-19 vaccine. The trial will examine the safety and efficacy of the vaccine in the U.S. It w...

Read More
TCR2 announces positive interim data from Phase 1 TC-210 trial

TCR2 Therapeutics Inc., a biotechnology company, has recently announced the positive interim data from the Phase 1 trial of its Phase 1/2 clinical study of TC-210. In the Phase 1 trial, the company had enrolled 5 patients diagnosed with mesothel...

Read More
Glenmark’s favipiravir trial shows 40% faster COVID-19 recovery

Glenmark Pharmaceuticals has recently announced the positive result from its Phase 3 clinical trial of favipiravir, a sought-after drug, which was conducted among the COVID-19 patients. The study has shown the effectiveness of the drug, enabling a fa...

Read More
Belite Bio announces successful Phase 1 clinical trials of AMD drug

San Diego-based clinical stage biopharmaceutical firm, Belite Bio has recently revealed positive data from Phase 1 trials conducted in Australia and the U.S. on LBS-008, an oral small molecule RBP4 (Retinol Binding Protein 4) specific ...

Read More
Moderna reveals positive results from Phase 1 Covid-19 vaccine trial

The dire need for a treatment for the coronavirus has compelled pharmaceutical companies worldwide to fast track clinical trials. U.S.-based biotech company, Moderna Inc. has recently made some developments, with its researchers claiming that their e...

Read More
CTI-Medidata partner to adopt Remote Source Review in clinical trials

CTI Clinical Trial and Consulting Services will reportedly adopt Remote Source Review of Medidata. Medidata is the end-to-end solutions provider to support the clinical trials. This contract research organization will use the service to upgrade the r...

Read More
NIMS begins subject enrollment for Phase 1 trial of COVID-19 vaccine

Nizam’s Institute of Medical Science (NIMS) has recently commenced the enrollment of subjects for its Phase 1 clinical trials of the COVID-19 vaccine. It is the 1st indigenous coronavirus vaccine candidate developed in India. Following the app...

Read More
Walmart to compete Amazon Prime with new subscription service, Walmart

U.S retail giant, Walmart Inc. has recently joined the race against Amazon with its latest subscription service, Walmart+. Similar to Amazon Prime, the new subscription service will endow Walmart customers with access to same-day delivery o...

Read More
Regeneron begins late-stage trial of its coronavirus antibody cocktail

Renowned American biopharmaceutical company, Regeneron Pharmaceuticals, has reportedly announced that it has started late-stage clinical trials of its proprietary antibody cocktail to assess its effectiveness in treating and preventing COVID-19. Acc...

Read More
China completes 2 launches in 3-day span with Gaofen & Shiyan-6

China has recently launched its classified Shiyan-6 (02) satellite, following the launch of Gaofen, which is a ‘multimode’ Earth observation satellite, into orbit 2 days earlier. These two launches will mark the 16th and 17th orbital laun...

Read More
Tetra Pak announces target to reach net-zero GHG emissions by 2030

Tetra Pak, a food processing and packaging solutions provider, has recently announced its target to reach net-zero GHG (greenhouse gas) emissions in its operations by 2030. The target of the company is to reach the net-zero emissions across the enti...

Read More
DTE Energy pledges to reach net-zero emissions of GHG by 2050

DTE Energy has reportedly pledged to reach the net-zero GHG (greenhouse gas) emissions by 2050. This can be ensured through various actions involving customers, suppliers, and its infrastructure, that align with the long-term goals for electric opera...

Read More
Researchers investigate a novel treatment for Childhood Alzheimer’s

Researchers at the Lundquist Institute have reportedly collaborated with the Cure Sanfilippo Foundation on a new clinical trial to investigate if repurposing an anti-inflammatory drug could provide relief to children that suffer from Sanfilippo syndr...

Read More
Amazon unveils $2 billion climate fund to help decarbonize economies

Amazon, the renowned technology and online retail giant, has reportedly announced a new initiative that would help efforts to develop sustainable technologies, products, and services that would allow Amazon and several other companies to fulfil the t...

Read More
Walmart collaborates with Shopify to expand online marketplace

Walmart has recently announced its collaboration with Shopify, an e-Commerce platform, to expand its online marketplace. The collaboration has been formed to gain an advantage over Amazon in gaining 3rd-party sellers. The recent deal has led to the ...

Read More
UAE launches WhatsApp service to access COVID-19 related information

United Arab Emirates (UAE) has reportedly launched a new WhatsApp service that will offer the latest, trustworthy, and accurate COVID-19 related information. This new service will cater to the residents and patients in the region who are maintaining ...

Read More
Flipkart launches Voice Assistant for enhanced shopping experiences

Flipkart, an Indian e-Commerce company, has reportedly launched the Voice Assistant platform on Supermart, its grocery store, to simplify the buying experience of the users. The voice assistant has been developed by the in-house technology team. It w...

Read More
FSD Pharma reveals temporary FDA approval to submit IND for FSD-201

FSD Pharma Inc. has recently announced the temporary approval from the U.S. FDA to submit an IND (Investigational New Drug) application for FSD-201 (ultramicronized PEA or palmitoylethanolamide). This will be used for the treatment of COVID-19 diseas...

Read More
URMC to initiate clinical trials to test HCQ in COVID-19 treatment

URMC researchers are going to join a couple of new national clinical trials in the coming week to be able to test if hydroxychloroquine (HCQ), which is essentially an anti-malarial drug approved by the FDA, will be able to keep the patients suffering...

Read More
Russia to start clinical trial of novel COVID-19 vaccine in 2 weeks

Russia has recently announced its plan to start the clinical trials of the potential COVID-19 vaccine within a period of two weeks. The health ministry in Russia has recently informed about the approval from the authorities to commence the trial pro...

Read More
AdaptHealth enters definitive deals to acquire Solara & ActivStyle

AdaptHealth Corp. has recently entered two separate definitive agreements for the acquisition of Solara Medical Supplies, LLC and ActivStyle, Inc. AdaptHealth is a leading home medical supplies, equipment, and other related services provider in the U...

Read More
Ambani’s JioMart unveils a new website to deliver orders across India

Jio Platforms, the top telecom operator along with Jio Retail, which is the top retail chain has recently unveiled JioMart’s new website and has begun taking orders in a large amount from tier 1, tier 2 and metro cities that also include Chenna...

Read More
Omada enters $30M acquisition deal with digital health company Physera

Omada Health, which has raised nearly $57 million in funding, has reportedly acquired a digital health company, Physera. It provides remote physical therapy to its customers. The coronavirus pandemic has led to an increased demand for online care se...

Read More
Sanofi will offer its first batch of COVID-19 vaccine to the U.S.

The company has collaborated with GlaxoSmithKline Plc to conduct this vaccine development project. French pharmaceutical giant, Sanofi has been making tremendous advancements in COVID-19 vaccine development. Recently, the biotech made a groundbreaki...

Read More
Glenmark initiates Favipiravir Phase 3 clinical study for COVID-19

Glenmark Pharmaceuticals Limited has reportedly begun the process for Favipiravir’s phase 3 clinical trials among the patients with coronavirus disease across India to be able to test both efficacy and safety of the antiviral drug. As per the ...

Read More
Moderna gains FDA approval to enter Phase 2 trial of mRNA-1273

Moderna Therapeutics, an American biotechnology company, has recently announced the FDA approval for its COVID-19 vaccine candidate, mRNA-1273 to enter the Phase 2 clinical trial. The 2nd phase of the vaccine development will involve nearly 600 peopl...

Read More
Stemline inks acquisition deal worth up to $677M with Menarini

Stemline Therapeutics, a commercial-stage biopharmaceutical company, has reportedly signed an acquisition deal with Menarini Group, an Italian pharmaceutical company. A New York-based company, Stemline, has developed the first drug approved by the F...

Read More
FedEx-BigCommerce form alliance to support small & medium businesses

FedEx Corporation has recently announced a new collaboration with an open SaaS e-Commerce platform, BigCommerce. The alliance has been made to enable the efficient functioning of small & medium businesses during the COVID-19 outbreak. The ongoin...

Read More
Tiziana files patent on combination of NP-ACT D with anti-IL-6R

Tiziana Life Sciences, a biotechnology company, has recently announced the filing of a provisional patent application on a potential therapy for the COVID-19 disease. This potential therapy is the combination of NP-ACT D (nanoparticle-Actinomycin D) ...

Read More
Reliance pilots new WhatsApp-based JioMart retail platform in India

Reliance recently initiated testing of its e-commerce portal JioMart, on WhatsApp, few days after Facebook announced plans to make a USD $5.7 billion investment in the company. An e-commerce project of Reliance Retail, JioMart went live in 3 ne...

Read More
Health Carousel launches HCLN for fast access to healthcare providers

Health Carousel has recently launched the HCLN (Health Carousel Locum Network) to enable fast access to a network of advanced practice providers and highly qualified physicians. A full suite of locum tenens specialties is being offered through the HC...

Read More
United Airlines plans to sell shares & raise $1B amid demand collapse

United Airlines Holdings Inc., a publicly traded airline holding company, is planning to sell its shares and raise over $1 billion. The company has taken up this initiative in an effort to increase its capital and survive the ongoing collapse in term...

Read More
DBT approves funding for 3 companies to develop COVID-19 vaccine

The Department of Biotechnology (DBT) in India has reportedly short-listed three companies and approves the funding for these companies to develop a COVID-19 vaccine. Additionally, it has received 13 funding proposals for therapeutics, diagnostics, a...

Read More
India forms task force for research & development of COVID-19 vaccine

India has recently formed a high-level task force to focus on the research and development of the coronavirus vaccine. Additionally, this task force will also coordinate with various international communities to surge the COVID-19 vaccine development...

Read More
Instacart & Costco team up to launch new prescription delivery service

Instacart, a US-based grocery delivery and pickup service company, has reportedly announced its plan to launch a new prescription delivery service in partnership with Costco, a renowned US-based membership-only store chain, as the need for online del...

Read More
Medopad rebrands as Huma & acquires startups BioBeats & TLT

Medopad, a British healthcare technology company, is reportedly rebranding itself as Huma and appointing Alan Milburn, the former U.K. Health Minister, as the first chairman. In addition, Huma is also announcing the acquisition of two startups, BioBe...

Read More
XTD agrees to $300K all-cash deal to secure oOh!media’s health network

XTD, a digital transit media company, has recently agreed to enter an all-cash deal of $300,000 to acquire the health network of oOh!media, a leading out-of-home advertising company. This health network operates in nearly 50 mega dental & medical...

Read More
Jollibee launches delivery service via DoorDash in U.S. & Canada

Jollibee, a Filipino multinational fast-food restaurant chain, has recently launched a delivery service in the U.S. and Canada via DoorDash. The company is also serving customers in these regions via carryout and drive-through services from its recen...

Read More
Kolon’s Invossa-K Phase 3 clinical trial to continue after FDA nod

Kolon Life Science has announced that it has received an approval to continue Invossa-K’s phase-3 clinical trial by the U.S. Food and Drug Administration. Invossa-K is a gene therapy for osteoarthritis and the trial is being run in the United S...

Read More
Amazon suspending delivery service that competes with FedEx and UPS

Amazon Inc., the renowned e-commerce and technology giant, has reportedly announced its plans to suspend its delivery service that focuses on competing with FedEx and UPS across the United States. The retail giant informed its customers that its ser...

Read More
HCA Healthcare, Google Cloud launch COVID-19 National Response Portal

American healthcare firm- HCA Healthcare and Google Cloud – a cloud platform offered by Google have reportedly joined hands to introduce COVID-19 National Response Portal, an open data platform network developed by SADA. Apparently, the platfo...

Read More
Walmart hastens store sanitization following employee deaths in Chicago

Walmart Inc., an American multinational retail corporation, has recently reported the death of two of its employees, who contracted the COVID-19 disease, in Chicago. This has significantly prompted the retail chain to reinforce additional safety and ...

Read More
HBO makes some of its content streaming free amid lockdown

With a major section of the world currently under lockdown, people are increasingly relying on quality video content and television series to pass their time in quarantine. As a result, several OTT platforms have started to offer free access to their...

Read More
Dr. Reddy’s confirms Naloxone Hydrochloride Injection launch in the US

Dr. Reddy’s Laboratories ,along with its subsidiaries, recently announced that the company has unveiled Naloxone Hydrochloride Injection USP, a prefilled Syringe of single-dose of 2mg/2mL which is a generic version of Narcan Injection USP, appr...

Read More
Wipro, PLEXIS to boost digital transformation for healthcare payers

The global healthcare industry is presently witnessing a major digital transformation. Operating an intelligent and efficient back-office is critical to boost productivity, quality, and revenue. Optimized technology to support intelligent operations ...

Read More
Apple to experience a shortage of replacement iPhones over next weeks

The coronavirus outbreak has been putting stress on the supply chain of tech giants, and despite the fact that Apple Inc. is optimistic about achieving long term goals, progress on short-term goals appear to be a bit uncertain. According to a new re...

Read More
Ant Financial invests in Klarna to enhance & innovate financial services

Known for its pioneering innovation in the global banking and payment sector, Klarna, a Swedish payment solution provider, has recently came into limelight as it announced that Ant Financial Services Group, operator and owner of Alipay, has bought in...

Read More
Karyopharm unveils positive results from Phase 3 BOSTON study

Karyopharm Therapeutics Inc., an innovation driven pharmaceutical company, has reportedly announced positive top-line results from its randomized Phase 3 BOSTON study assessing once-weekly XPOVIO® (selinexor) coupled with once-weekly Velcade®...

Read More
U.S. HHS to probe production of defective coronavirus test kits

The United States Department of Health and Human Services (HHS) has reportedly announced that the agency is examining early coronavirus test kits for manufacturing defects that led few states to get emergency permission to use their own COVID-19 test...

Read More
Puma secures FDA approval for sNDA for patients with breast cancer

Puma Biotechnology, Inc., a leading biopharma firm, recently announced that its supplemental New Drug Application (sNDA) for neratinib has received approval from the U.S. FDA. Combined with capecitabine, sNDA will treat adult patients suffering from ...

Read More
Tetra commences PoC clinical trial of PPP003v for companion dogs

Tetra Bio-Pharma Inc., a Canadian pharmaceutical firm that specializes in cannabinoid-derived drug therapy, has recently initiated a clinical study of synthetic cannabinoid therapy (PPP003v) for ophthalmic eye pain in veterinary setting. Reportedly,...

Read More
Satipharm begins clinical trial of CBD capsules for treating menopause

Cannabis was prior considered to possess various medicinal benefits for treating diseases. However, after years of restriction, the scientific community is finally exploring the medical avenues of CBD by conducting advanced clinical trials and creati...

Read More
Walmart reveals international sales numbers; Flipkart leads the chart

American multinational retail company, Walmart, Inc. has recently revealed that ecommerce has led to 12% to its international sales. Apparently, these sales were led by its online grocery delivery platform and Flipkart. In its Q4 earnings report, Wa...

Read More
Voyager Digital buys Circle Invest to expand retail customer base

Voyager Digital Canada Ltd. – a digital wealth management firm based in New York, United States has reportedly signed an agreement to purchase Circle Invest- a digital asset management subsidiary of Circle Internet Financial, Inc. For the reco...

Read More
CytRx publishes results from Arimoclomol Phase 2 trial for sIBM

CytRx Corporation, a biopharmaceutical firm that specializes principally in neurodegenerative and oncology diseases, recently announced its data from Orphazyme double-blinded Phase 2 study of arimoclomol for the treatment of sIBM (Sporadic Inclusion ...

Read More
FDA grants Priority Review of NDA for Astex's oral C-DEC

Astex Pharmaceuticals, Inc., a subsidiary of Otsuka Pharmaceutical Co. Ltd., announced that it has received Priority Review for its NDA for oral C-DEC (cedazuridine and decitabine) by the U.S. Food and Drug Administration (FDA). Oral C-DEC is a treat...

Read More
Sanofi’s BTK inhibitor meets primary endpoint in Phase 2b to treat MS

MS (multiple sclerosis) is a serious disease that affects about 1.2 million people across the U.S. and Europe. The ailment is a chronic disease that attacks the CNS (central nervous system). Today, despite present therapies, several MS patients conti...

Read More
Corvus Pharmaceuticals unveils updated data from Phase 1/1b trial

Corvus Pharmaceuticals, Inc., a clinical-stage science driven biopharmaceutical firm focusing on the commercialization and development of precisely targeted oncology therapies along with biomarker patient enrichment selection, has reportedly announce...

Read More
Timber Pharmaceuticals and BioPharmX Corp. inks merger agreement

A specialty pharmaceutical company, BioPharmX Corporation and a privately held biopharmaceutical company, Timber Pharmaceuticals LLC, which is focused on developing and commercializing treatments for orphan dermatologic diseases, recently announ...

Read More
Nestlé acquires Allergan’s Zenpep to expand medical nutrition business

Nestle, a Swiss food and beverage giant, has recently expanded its medical nutrition business by entering an asset purchase agreement to acquire Allergans Zenpep, for undisclosed sum. Nestle will take ownership of Zenpep upon closing the strateg...

Read More
Nestle introduces three new flavors of the beloved Smarties Buttons

  The company has introduced three new Smarties Buttons flavors hitting stores this week Smarties Buttons will be available in mouth-watering white, milk and orange chocolate flavors Single packs will cost 65p while the sharing packs will b...

Read More
New Medtronic Micra AV pacemaker receives approval from the U.S. FDA

Medtronic plc, a renowned US-based medical device company, reportedly announced that its Micra AV pacemaker has received approval from the U.S. FDA. The Medtronic Micra AV is the world’s smallest pacemaker with AV (atrioventricular) synchrony. ...

Read More
Health Canada grants two DIN to new Tetra Bio-pharma OTC products

Tetra Bio-pharma, a renowned Canadian biopharmaceutical company, reportedly announced that Health Canada, the regulatory health authority of Canada, has granted two new DIN (Drug Identification Numbers) for the first OTC (over-the-counter) products t...

Read More
Digital River & Magento team-up to create customized commerce solution

Digital River, a renowned global ecommerce facilitator for well-known and fast-growing brands, has reportedly signed a new strategic partnership deal with Magento, a leading provider of commerce innovations to retailers and brands throughout industri...

Read More
Innate Pharma announces regulatory updates for TELLOMAK Phase II study

Innate Pharma SA, a commercial biopharmaceutical firm involved in the development of immunotherapy drug candidates to treat cancer and inflammatory diseases, has recently announced a regulatory update concerning the TELLOMAK Phase II trial aimed at e...

Read More
Alibaba forays into Europe by proposing lower seller fees than Amazon

Retail major Alibaba has decided to make its move in European markets after years of exploration. The company will undercut Amazon sellers’ fess with an aim to attract vendors but has experienced mixed results. AliExpress, the European platform...

Read More
Luckin Coffee announces the launch of smart coffee vending machines

Chinese coffee chain, Luckin Coffee Inc. is supposedly trying to expand its market reach by adopting advanced technologies. Recently, the firm revealed plans to enter the unmanned retail market by introducing its "luckin popMINI" smart vend...

Read More
Walmart teams-up with SmileDirectClub to sell dental care products

Walmart, a renowned American multinational retail corporation, has reportedly teamed-up with teledentistry company, SmileDirectClub, as it looks to acquire a bigger share of the $3.5 trillion American healthcare industry. As per reports, the partner...

Read More
Reliance Industries unveils its new online grocery platform, JioMart

After ruling the broadband and telecom sector of India, Reliance Industries Ltd. has reportedly launched its new e-commerce platform called JioMart. With this move, the Indian giant aims on competing against behemoths like Flipkart and Amazon. Opera...

Read More
AstraZeneca and Merck attain FDA nod for a pancreatic cancer drug

The drug, dubbed Lynparza, is currently approved in almost 65 countries for the maintenance treatment of platinum-sensitive lapsed ovarian cancer. British pharmaceutical firm AstraZeneca and Merck & Co. Inc. recently announced that its drug cand...

Read More
OBI Pharma bags FDA Orphan Drug Designation for cancer drug, OBI-999

Taiwan-based biopharmaceutical firm, OBI Pharma, Inc. has reportedly been granted the Orphan Drug Designation by the U.S. FDA (Food and Drug Administration) for Pancreatic Cancer treatment OBI-999. Sources claim that the Phase 1/2 clinical trial...

Read More